Customers who bought this item also bought

• Stakeholder Opinions: HIV in Emerging Markets (Brazil, Russia, India) - Growing need for second- and third-line therapies boosts commercial opportunity
• Special Report: Evolving Patterns and Unmet Needs in the TB Population in Developing and Developed Markets
• Nitric Oxide - Therapeutics, Markets and Companies
• Disease & Therapy Review (DTR) Executive Market Summaries
• Forecast Insight: HIV - Increasing dominance of fixed dose combinations raises bar for single agents
• Evolving Patterns and Unmet Needs in the TB Population in Developing and Developed Markets
• The 2012 Healthcare Business Market Research Handbook
• Personalized Medicine Market Potential
• The Incidence and Prevalence Database: Global Incidence, Prevalence, Morbidity, Comorbidity, Cost Data, Symptoms and Many Other Health Issues for over 4,500 Diseases and Procedures
• International Donor Funding for the Healthcare Industry in Key Sub-Saharan African Countries: Historical Data and Identified Ongoing Funding Sources

Antiretroviral treatment in Pretoria: Issues and Outcomes. Edition No. 1

VDM Publishing House, October 2010, Pages: 360

The decision to roll-out antiretroviral treatment in the public health care facilities in South Africa was taken in November 2003. This monograph is about the experiences of patients and outcomes of treatment. It starts by discussing the theories about the Human Immuno-deficiency Virus, the medicines used against it, and goes on to describe how the study was conducted. At the core, its presents the findings, followed by their discussion and ends with some concluding remarks and recommendations.

Ntambwe, Malangu.
Ntambwe Malangu is a public health specialist with over 10 years of experience in International Health, Academic Medicine, and Health Systems Research. Malangu holds a Bachelor degree in Pharmacy, a Master of Medical Sciences degree in Pharmacology, and a Doctor of Philosophy degree.